Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2018 185 52 134,793,211      
Beginning Balance, Amount at Dec. 31, 2018 $ 1,340,566 $ 362,059 $ 134,792 $ 127,570,709 $ (123,171,406) $ 6,236,720
Shares issued directors, shares 1,197,280      
Shares issued to directors, value $ 1,198 130,802 132,000
Stock-based compensation expense related to employee stock options 7,262 7,262
Net loss attributable to common stockholders (1,934,133) (1,934,133)
Ending Balance, Shares at Dec. 31, 2019 185 52 135,990,491      
Ending Balance, Amount at Dec. 31, 2019 $ 1,340,566 $ 362,059 $ 135,990 127,708,773 (125,105,539) 4,441,849
Shares issued directors, shares 320,844      
Shares issued to directors, value $ 321 17,679 18,000
Stock-based compensation expense related to employee stock options 7,262 7,262
Net loss attributable to common stockholders (3,149,852) (3,149,852)
Ending Balance, Shares at Dec. 31, 2020 185 52 136,311,335      
Ending Balance, Amount at Dec. 31, 2020 $ 1,340,566 $ 362,059 $ 136,311 $ 127,733,714 $ (128,255,391) $ 1,317,259